Indonesia says sinovac vaccine is over 90% effective based on front liners results.
Prognosis
China Sinovac Shot Seen Highly Effective in Real World Study
Bloomberg News
12 May 2021, 05:00 GMT+8Updated on 12 May 2021, 15:42 GMT+8
- Indonesia health workers 96% protected against hospitalization
- Developing countries can’t vaccinate populations fast enough
Sinovac CEO Yin Discusses CoronaVac's Efficacy
Unmute
WATCH: Sinovac Biotech CEO Yin Weidong discusses CoronaVac's efficacy rate, exportation of the vaccine, and new findings on how it works against variants.
Sinovac Biotech Ltd.’s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical trials.
Indonesia tracked 128,290 health workers in capital city Jakarta from January to March and found that the vaccine protected 98% of them from death and 96% from hospitalization as soon as seven days after the second dose, Pandji Dhewantara, a Health Ministry official who oversaw the study, said in a Wednesday press conference.
Dhewantara also said that 94% of the workers had been protected against symptomatic infection -- an extraordinary result that goes beyond what was measured in the shot’s numerous clinical trials. Health Minister Budi Gunadi Sadikin earlier revealed a smaller version of the study involving 25,374 people in a Tuesday interview with Bloomberg that had the same effectiveness data for hospitalization and infection. Protection against death was 100% in the smaller group.
